Clinical Trial Details
— Status: Terminated
Administrative data
NCT number |
NCT05729425 |
Other study ID # |
21-005183 |
Secondary ID |
NCI-2022-0960921 |
Status |
Terminated |
Phase |
|
First received |
|
Last updated |
|
Start date |
October 31, 2022 |
Est. completion date |
August 15, 2023 |
Study information
Verified date |
August 2023 |
Source |
Mayo Clinic |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
This study evaluates the accuracy of a new ultrasound technology called microvessel imaging
for detecting the extent of disease among patients with angiosarcoma of the skin. Microvessel
ultrasound imaging uses high frequency waves to visualize vessels in the skin that are not
easily seen using other imaging tests.
Description:
PRIMARY OBJECTIVE:
I. To determine the accuracy of depicting extent of disease of cutaneous angiosarcoma before
and after neoadjuvant treatment compared to clinical photographs, magnetic resonance imaging
(MR) or positron emission tomography (PET)/computed tomography (CT) imaging and surgical
pathology both on skin biopsies and surgical excision.
OUTLINE:
Patients undergo microvessel ultrasound imaging on study.